Skip to main content Accessibility help
×
Home

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade

  • E. Barkhof (a1), C.J. Meijer (a1), L.M.J. de Sonneville (a2), D.H. Linszen (a1) and L. de Haan (a1)...

Abstract

Objective

Nonadherence to antipsychotic medication is highly prevalent in patients with schizophrenia and has a deleterious impact on the course of the illness. This review seeks to determine the interventions that were examined in the past decade to improve adherence rates.

Method

The literature between 2000 and 2009 was searched for randomized controlled trials which compared a psychosocial intervention with another intervention or with treatment as usual in patients with schizophrenia.

Results

Fifteen studies were identified, with a large heterogeneity in design, adherence measures and outcome variables. Interventions that offered more sessions during a longer period of time, and especially those with a continuous focus on adherence, seem most likely to be successful, as well as pragmatic interventions that focus on attention and memory problems. The positive effects of adapted forms of Motivational Interviewing found in earlier studies, such as compliance therapy, have not been confirmed.

Conclusion

Nonadherence remains a challenging problem in schizophrenia. The heterogeneity of factors related to nonadherence calls for individually tailored approaches to promote adherence. More evidence is required to determine the effects of specific interventions.

Copyright

Corresponding author

* Corresponding author. Tel.: +31 20 8913500; fax: +31 20 8913702. E-mail address:e.barkhof@amc.uva.nl (E. Barkhof).

References

Hide All
[1]Agarwal, MRSharma, VKKishore Kumar, KVLowe, DNon-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry. 1998; 44(2): 9210610.1177/002076409804400202
[2]Atkinson, JMCoia, DAGilmour, WH, et al.The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry. 1996;168:19920410.1192/bjp.168.2.199
[3]Azrin, NHTeichner, GEvaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther. 1998;36:84986110.1016/S0005-7967(98)00036-9
[4]Battle, EHHalliburton, AWallston, KASelf-medication among psychiatric patients and adherence after discharge. J Psychosoc Nurs Ment Health Serv. 1982;20:2128
[5]Becker, MHMaimon, LASociobehavioural determinants of compliance with health and medical care recommendations. Med Care. 1975;13:102410.1097/00005650-197501000-00002
[6]Beebe, LHSmith, KCrye, C, et al.Telenursing intervention increases psychiatric medication adherence in schizophrenia outpatients. J Am Psychiatr Nurses Assoc. 2008; 14(3): 21722410.1177/1078390308318750
[7]Bigelow, DAMcFarland, BHGareau, MJYoung, DJImplementation and effectiveness of a bed reduction project. Community Ment Health J. 1991;27:12513310.1007/BF00752815
[8]Boczkowski, JAZeichner, ADeSanto, NNeuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychiatry. 1985;53:66667110.1037/0022-006X.53.5.666
[9]Bond, GRMiller, LDKrumwied, RDWard, RSAssertive case management in three CMHCs: a controlled study. Hosp Community Psychiatry. 1988;39:411418
[10]Bond, GRWitheridge, TFWasmer, D, et al.A comparison of two crisis housing alternatives to psychiatric hospitalization. Hosp Community Psychiatry. 1989;40:177183
[11]Bond, GRMcDonel, ECMiller, LDPensec, MAssertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosoc Rehabil J. 1991;15:3043
[12]Brown, CSWright, RGChristensen, DBAssociation between type of medication instruction and patients’ knowledge, side effects, and compliance. Hosp Community Psychiatry. 1987;38:5560
[13]Buchanan, AA two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med. 1992; 22(3): 78779710.1017/S0033291700038228
[14]Buchkremer, GKlingberg, SHolle, RSchulze Monking, HHornung, WPPsychoeducational psychotherapy for schizophrenic patients and their key relatives or caregivers: results of a 2-year follow-up. Acta Psychiatr Scand. 1997;96:48349110.1111/j.1600-0447.1997.tb09951.x
[15]Buckley, PFCorrel, CUStrategies for dosing and switching antipsychotics for optimal clinical management. J Clin Psychiatry. 2008; 67(S1): 17
[16]Bush, CTLangford, MWRosen, PGott, WOperation outreach: intensive case management for severely psychiatrically disabled adults. Hosp Community Psychiatry. 1990;41:647649
[17]Byerly, MJThompson, ACarmody, T, et al.Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv. 2007;58:84484710.1176/ps.2007.58.6.844
[18]Chan, SWYip, BTso, SCheng, BSTam, WEvaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ Couns. 2009; 75(1): 677610.1016/j.pec.2008.08.028
[19]Chien, WTChan, SWThompson, DREffects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. Br J Psychiatry. 2006;189:414910.1192/bjp.bp.105.008375
[20]Claassen, DFakhoury, WKFord, RPriebe, SMoney for medication: financial incentives to improve medication adherence in assertive outreach. Psychiatr Bull. 2007;31:4710.1192/pb.31.1.4
[21]Connor, JRafter, NRodgers, ADo fixed-dose combination pills or unit-of-packaging improve adherence? A systematic review. Bull World Health Organ. 2004;82:935939
[22]Cramer, JARosenheck, RCompliance with medical regimes for mental and physical disorders. Psychiatr Serv. 1998;49:19620110.1176/ps.49.2.196
[23]De Haan, LLavalaye, Jvan Bruggen, M, et al.Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Can J Psychiatry. 2004; 49(5): 290296
[24]Diaz, ENeuse, ESullivan, MCPearsall, HRWoods, SWAdherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry. 2004; 65(3): 35436010.4088/JCP.v65n0311
[25]Dixon, LWeiden, PTorres, MLehman, AAssertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry. 1997;154:13021304
[26]Dolder, CRLacro, JPLeckband, SJeste, DVInterventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol. 2003; 23(4): 389399
[27]Eckman, TALiberman, RPPhipps, CCTeaching medication management skills to schizophrenic patients. J Clin Psychopharmacol. 1990;10:333810.1097/00004714-199002000-00006
[28]Elvevåg, BMaylor, EAGilbert, ALHabitual prospective memory in schizophrenia. BMC Psychiatry. 2003;3:910.1186/1471-244X-3-9
[29]Falloon, IRMcGill, CWBoyd, JLPederson, JFamily management in the prevention of morbidity of schizophrenia. Arch Gen Psychiatry. 1985;42:88789610.1001/archpsyc.1985.01790320059008
[30]Fenton, WSBlyler, CRHeinssen, RKDeterminants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997; 23(4): 63765110.1093/schbul/23.4.637
[31]Ford, RBeadsmore, ARyan, PRepper, JCraig, TMuijen, MProviding the safety net: case management for people with serious mental illness. J Ment Health. 1995;1:919710.1080/09638239550037893
[32]Frank, AFGunderson, JGThe role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Arch Gen Psychiatry. 1990; 47(3): 22823610.1001/archpsyc.1990.01810150028006
[33]Gilbert, PLHarris, MJMcAdams, LAJeste, DVNeuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry. 1995; 52(3): 17318810.1001/archpsyc.1995.03950150005001
[34]Glick, IDClarkin, JFHaas, GLSpencer, JHA randomized clinical trial of inpatient family intervention. VI: mediating variables and outcome. Fam Process. 1991;30:859910.1111/j.1545-5300.1991.00085.x
[35]Gray, RDoes patients education enhance compliance with clozapine? A preliminary investigation. J Psychiatr Ment Health Nurs. 2000;7:285286
[36]Gray, RWykes, TEdmonds, MLeese, MGournay, KEffect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. Br J Psychiatry.. 2004;185:157162
[37]Gray, RLeese, MBindman, J, et al.Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry. 2006;189:508514
[38]Greenberg, RNOverview of patient compliance with medication dosing: a literature review. Clin Ther. 1984; 6(5): 592599
[39]Giuffrida, ATorgerson, DJShould we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997; 315(7110): 703707
[40]Guimon, LEguiluz, IBulbena, AGroup pharmacotherapy in schizophrenics: attitudinal and clinical changes. Eur J Psychiatry. 1993;7:147154
[41]Harris, NLovell, KDay, JRoberts, CAn evaluation of a medication management training programme for community mental health professionals; service user level outcomes. A cluster randomised controlled trial. Int J Nurs Stud. 2008;46:645652
[42]Hayward, PChan, NKemp, R, et al.Medication self-management: a preliminary report on an intervention to improve medication compliance. J Ment Health. 1995;4:511517
[43]Herz, MIPsychosocial treatment. Psychiatr Ann. 1996;26:531535
[44]Hogarty, GEAnderson, CMReiss, DJ, et al.Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, I: one-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry. 1986;43:633642
[45]Hogarty, GEAnderson, CMReiss, DJ, et al.Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry. 1991;48:340347
[46]Hogarty, GEKornblith, SJGreenwald, D, et al.Three-year trials of personal therapy among schizophrenic patients living with or independent of family. I: description of study and effects on relapse rates. Am J Psychiatry. 1997;154:15041513
[47]Hornung, WPKieserg, AFeldmann, RBuchkremer, GPsychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns. 1996;29:257268
[48]Hornung, WPKlingberg, SFeldmann, RSchonauer, KSchulze Monking, HCollaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand. 1998;97:21321910.1111/j.1600-0447.1998.tb09990.x
[49]Hudson, TJOwen, RRThrush, CR, et al.Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J Clin Psychiatry. 2008;69:7480
[50]Jeste, SDPatterson, TLPalmer, BWDolder, CRGoldman, SJeste, DVCognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res. 2003; 63(1–2–): 4958
[51]Kashner, TMRader, LERodell, DEBeck, CMRodell, LRMuller, KFamily characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hosp Community Psychiatry. 1991;42:195197
[52]Kelly, GRScott, JAMedication compliance and health education among outpatients with chronic mental disorders. Med Care. 1990;28:11811197
[53]Kemp, RHayward, PApplewhaite, GEveritt, BDavid, ACompliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996; 312(10): 34534910.1136/bmj.312.7027.345
[54]Kemp, RKirov, GEveritt, BHayward, PDavid, ARandomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry. 1998;172:413419
[55]Klingberg, SSchneider, SWittorf, ABuchkremer, GWiedemann, GCollaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Psychiatry Res. 2008; 161(2): 22523410.1016/j.psychres.2007.07.027
[56]Lacro, JPDunn, LBDolder, CRLeckband, SGJeste, DVPrevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002; 63(10): 892909
[57]Leff, JKuipers, LBerkowitz, RSturgeon, DA controlled trial of social interventions in the families of schizophrenia patients: two-year follow-up. Br J Psychiatry. 1985;146:594600
[58]Leff, JBerkowitz, RShavit, NStrachan, AGlass, IVaughn, CA trial of family therapy versus a relatives group for schizophrenia. Br J Psychiatry. 1989;154:5866
[59]Leff, JBerkowitz, RShavit, NStrachan, AGlass, IVaughn, CA trial of family therapy versus a relatives group for schizophrenia: two-year follow-up. Br J Psychiatry. 1990;157:571577
[60]Lehman, AFKreyenbuhl, JBuchanan, RW, et al.The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull. 2004; 30(2): 19321710.1093/oxfordjournals.schbul.a007071
[61]Leucht, SBarnes, TRKissling, WEngel, RRCorrell, CKane, JMRelapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry. 2003; 160(7): 12091222
[62]Leucht, SHeres, SEpidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry. 2006; 67(S5): 38
[63]Li, ZArthur, DFamily education for people with schizophrenia in Beijing, China. Br J Psychiatry. 2005;187:339345
[64]Lindenmayer, JPLiu-Seifert, HKulkarni, PM, et al.Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with sub-optimal prior response. J Clin Psychiatry. 2009; 70(7): 990996
[65]Linszen, DDingemans, PVan Der Does, JW, et al.Treatment, expressed emotion, and relapse in recent onset schizophrenic disorders. Psychol Med. 1996;26:333342
[66]McEvoy, JPFreter, SEverett, G, et al.Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis. 1989; 177(1): 4851
[67]McFarlane, WRLukens, ELink, B, et al.Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry. 1995;52:679687
[68]Macpherson, RJerrom, BHughes, AA controlled study of education about drug treatment in schizophrenia. Br J Psychiatry. 1996;168:709717
[69]Malm, UThe influence of group therapy on schizophrenia. Acta Psychiatr Scand. 297Suppl.1982 16510.1111/j.1600-0447.1982.tb00288.x
[70]Maneesakorn, SRobson, DGournay, K, et al.An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs. 2007;16:13021312
[71]Merinder, LBViuff, AGLaugesen, HDClemmensen, KMisfelt, SEspensen, BPatient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol. 1999;34:287294
[72]Miller, WRRollnick, SMotivational interviewing: preparing people for change. New York: Guilford Press; 2002.
[73]Modrcin, MRapp, CAPoertner, JThe evaluation of case management services with the chronically mentally ill. Eval Program Plann 1988; 11: 307314
[74]Möller, HJClinical evaluation of negative symptoms in schizophrenia. Eur Psychiatry 2007; 22: 380386
[75]Morken, GGrawe, RWWiden, JHEffects of an integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia. J Clin Psychiatry 2007;68(4):566571
[76]Newcomer, JWHaupt, DWThe metabolic effects of antipsychotic medications. Can J Psych 2006; 51: 480491
[77]O’Donnell, CDonohoe, GSharkey, L, et al.Compliance therapy: a randoimised cotrolled trail in schizophrenia. BMJ 2003;327(7419):834
[78]Perkins, DOAdherence to antipsychotic medications. J Clin Psychiatry 60Suppl. 211999 2530
[79]Petersen, LJeppesen, PThorup, AAbel, MBØhlenschlaeger, J, et al.A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005;331(7517):602
[80]Pijnenborg, GHWithaar, FKBrouwer, WHTimmerman, MEvan den Bosch, RJEvans, JJThe efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia. Br J Clin Psychol 2009 [Epub].
[81]Priebe, SBurton, AAshby, D, et al.Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients – a cluster randomised controlled trial (FIAT). BMC Psychiatry 2009;9:61
[82]Ran, MSXiang, MZChan, CL, et al.Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia-a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 2003;38(2):6975
[83]Razali, MSYahya, HCompliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 1995; 91: 33133510.1111/j.1600-0447.1995.tb09790.x
[84]Razali, SMHasanah, CIKhan, ASubramaniam, MPsychosocial interventions for schizophrenia. J Ment Health 2000; 9: 28328910.1080/713680246
[85]Remington, GJAdams, MEDepot neuroleptic therapy: clinical considerations. Can J Psychiatry 403 Suppl. 11995 S5S11
[86]Robinson, DWoerner, MAlvir, J, et al.Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241247
[87]Robinson, DGWoerner, MGAlvir, JMBilder, RMHinrichsen, GALieberman, JAPredictors of medication discontinuation by patients with first episode schizophrenia and schizoaffective disorder. Schizophr Res 2002; 57: 209219
[88]Sands, RGCnaan, RATwo models of case management: assessing their impact. Community Ment Health J 1994; 30: 441457
[89]Schooler, NRKeith, SJSevere, JB, et al.Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment. Arch Gen Psychiatry 1997; 54: 453463
[90]Schooler, NRRelapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry 64Suppl. 162003 1417
[91]Seltzer, ARoncar, IGarfinkel, PEffect of patient education on medication compliance. Can J Psychiatry 1980; 25: 638645
[92]Solomon, PDraine, JThe efficacy of a consumer case management team: 2-year outcomes of a randomized trial. J Ment Health Adm 1995; 22: 135146
[93]Spaniel, FVohlídka, PHrdlicka, J, et al.ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res 2008; 98: 312317
[94]Stein, LITest, MAAlternative to mental hospital treatment. I: conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry 1980; 37: 392397
[95]Strang, JSFalloon, IRMoss, HBRazani, JBoyd, JLThe effects of family therapy on treatment compliance in schizophrenia. Psychopharmacol Bull 1981; 17: 8788
[96]Streicker, SKAmdur, MDincin, JEducating patients about psychiatric medications: failure to enhance compliance. Psychosoc Rehabil J 1986; 4: 1528
[97]Tarrier, NThe community management of schizophrenia: a controlled trial of a behavioural intervention with families to reduce relapse. Br J Psychiatry 1988; 153: 532542
[98]Telles, CKarno, MMintz, J, et al.Immigrant families coping with schizophrenia: behavioural family intervention v case management with a low-income Spanish-speaking population. Br J Psychiatry 1995; 167: 473479
[99]Turner, EHMatthews, AMEftihia Linardatos, E, et al.Selective publication of antidepressant trials and its onfluence on apparent Efficay. N Eng J Med 2008; 358: 252260
[100]Uzenoff, SRPerkins, DOHamer, RMWiesen, CAPenn, DLA preliminary trial of adherence-coping-education (ACE) therapy for early psychosis. J Nerv Ment Dis 2008; 196: 572575
[101]Valenstein, MKavanagh, JLee, Tet al. Using a pharmacy-based intervention to improve antispychotic adherence among patients with serious mental illness. Schizophr Bull 2009 [Epub Nov 21:1–10].
[102]Van Putten, PWhy do schizophrenic patients refuse to take their drugs?. Arch Gen Psychiatry 1974; 31: 6772
[103]Van Putten, TCrumpton, EYale, CDrug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry 1976;33(12):14431446
[104]Velligan, DILam, YWGlahn, DC, et al.Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006; 32: 724742
[105]Velligan, DIWang, MDiamond, P, et al.Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 2007;58(9):11871192
[106]Velligan, DIDiamond, PMMintz, J, et al.The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull 2008;34(3):483493
[107]Velligan, DIWeiden, PJSajatovic, M, et al.The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 70Suppl. 42009 146
[108]Weiden, PJShaw, EMann, JCauses of neuroleptic noncompliance. Psychiatr Ann 1986; 16: 571575
[109]Weiden, PIOlfson, MCost of relapse in schizophrenia. Schizophr Bull 1995; 21: 419429
[110]Weiden, PJKozma, CGrogg, ALocklear, JPartial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. J Psychiatr Serv 2004;55(8):88689110.1176/appi.ps.55.8.886
[111]Xiang, MRan, MLi, SA controlled evaluation of psychoeducational family intervention in a rural Chinese community. Br J Psychiatry 1994; 165: 544548
[112]Xiong, WPhillips, MRXiong, H, et al.Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry 1994; 165: 239247
[113]Young, JLZonana, HVShepler, LMedication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 1986; 14: 105122
[114]Zhang, MWang, MLi, JPhillips, MRRandomised-control trial of family intervention for 78 first-episode male schizophrenic patients: an 18-month study in Suzhou, Jiangsu. Br J Psychiatry Suppl 1994; 24: 96102
[115]Zygmunt, AOlfson, MBoyer, CAMechanic, DInterventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002;159(10):16531664

Keywords

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade

  • E. Barkhof (a1), C.J. Meijer (a1), L.M.J. de Sonneville (a2), D.H. Linszen (a1) and L. de Haan (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Interventions to improve adherence to antipsychotic medication in patients with schizophrenia–A review of the past decade

  • E. Barkhof (a1), C.J. Meijer (a1), L.M.J. de Sonneville (a2), D.H. Linszen (a1) and L. de Haan (a1)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *